mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.5 |
5e-12 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-11 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
9e-11 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |